ID   ABCG2_RAT               Reviewed;         657 AA.
AC   Q80W57; Q80ST1; Q80UR3; Q80XF3;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   24-JUL-2024, entry version 153.
DE   RecName: Full=Broad substrate specificity ATP-binding cassette transporter ABCG2 {ECO:0000305};
DE            EC=7.6.2.2 {ECO:0000250|UniProtKB:Q9UNQ0};
DE   AltName: Full=ATP-binding cassette sub-family G member 2;
DE   AltName: Full=Breast cancer resistance protein 1 homolog;
DE   AltName: Full=Urate exporter;
DE   AltName: CD_antigen=CD338;
GN   Name=Abcg2; Synonyms=Bcrp1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=12819005; DOI=10.1016/s0002-9440(10)63624-3;
RA   Shimano K., Satake M., Okaya A., Kitanaka J., Kitanaka N., Takemura M.,
RA   Sakagami M., Terada N., Tsujimura T.;
RT   "Hepatic oval cells have the side population phenotype defined by
RT   expression of ATP-binding cassette transporter ABCG2/BCRP1.";
RL   Am. J. Pathol. 163:3-9(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], GLYCOSYLATION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Brain capillary;
RX   PubMed=15255930; DOI=10.1111/j.1471-4159.2004.02537.x;
RA   Hori S., Ohtsuki S., Tachikawa M., Kimura N., Kondo T., Watanabe M.,
RA   Nakashima E., Terasaki T.;
RT   "Functional expression of rat ABCG2 on the luminal side of brain
RT   capillaries and its enhancement by astrocyte-derived soluble factor(s).";
RL   J. Neurochem. 90:526-536(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RA   Yabuuchi H., Ishikawa T.;
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 506-657.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain endothelium;
RA   Zhang W., Stanimirovic D.B.;
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=18451542; DOI=10.1248/bpb.31.1032;
RA   Ogura J., Kobayashi M., Itagaki S., Hirano T., Iseki K.;
RT   "Post-transcriptional regulation of breast cancer resistance protein after
RT   intestinal ischemia-reperfusion.";
RL   Biol. Pharm. Bull. 31:1032-1035(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Broad substrate specificity ATP-dependent transporter of the
CC       ATP-binding cassette (ABC) family that actively extrudes a wide variety
CC       of physiological compounds, dietary toxins and xenobiotics from cells.
CC       Involved in porphyrin homeostasis, mediating the export of
CC       protoporphyrin IX (PPIX) from both mitochondria to cytosol and cytosol
CC       to extracellular space, it also functions in the cellular export of
CC       heme. Also mediates the efflux of sphingosine-1-P from cells. Acts as a
CC       urate exporter functioning in both renal and extrarenal urate excretion
CC       (By similarity). In kidney, it also functions as a physiological
CC       exporter of the uremic toxin indoxyl sulfate (By similarity). Also
CC       involved in the excretion of steroids like estrone 3-sulfate/E1S,
CC       3beta-sulfooxy-androst-5-en-17-one/DHEAS, and other sulfate conjugates
CC       (By similarity). Mediates the secretion of the riboflavin and biotin
CC       vitamins into milk. Extrudes pheophorbide a, a phototoxic porphyrin
CC       catabolite of chlorophyll, reducing its bioavailability (By
CC       similarity). Plays an important role in the exclusion of xenobiotics
CC       from the brain. It confers to cells a resistance to multiple drugs and
CC       other xenobiotics including mitoxantrone, pheophorbide, camptothecin,
CC       methotrexate, azidothymidine, and the anthracyclines daunorubicin and
CC       doxorubicin, through the control of their efflux (By similarity). In
CC       placenta, it limits the penetration of drugs from the maternal plasma
CC       into the fetus. May play a role in early stem cell self-renewal by
CC       blocking differentiation (By similarity).
CC       {ECO:0000250|UniProtKB:Q7TMS5, ECO:0000250|UniProtKB:Q9UNQ0}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + xenobioticSide 1 = ADP + phosphate +
CC         xenobioticSide 2.; EC=7.6.2.2;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + urate(in) = ADP + H(+) + phosphate + urate(out);
CC         Xref=Rhea:RHEA:16461, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17775, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16462;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + indoxyl sulfate(in) = ADP + H(+) + indoxyl
CC         sulfate(out) + phosphate; Xref=Rhea:RHEA:61332, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:144643, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q7TMS5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61333;
CC         Evidence={ECO:0000250|UniProtKB:Q7TMS5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + sphing-4-enine 1-phosphate(in) = ADP + H(+) +
CC         phosphate + sphing-4-enine 1-phosphate(out); Xref=Rhea:RHEA:38951,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:60119, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38952;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + estrone 3-sulfate(in) + H2O = ADP + estrone 3-
CC         sulfate(out) + H(+) + phosphate; Xref=Rhea:RHEA:61348,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:60050, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61349;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + dehydroepiandrosterone 3-sulfate(in) + H2O = ADP +
CC         dehydroepiandrosterone 3-sulfate(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:61364, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57905,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61365;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-methylumbelliferone sulfate(in) + ATP + H2O = 4-
CC         methylumbelliferone sulfate(out) + ADP + H(+) + phosphate;
CC         Xref=Rhea:RHEA:61368, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:144581,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61369;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-
CC         benzothiazol-6-yl beta-D-glucuronate(in) + ATP + H2O = 5,7-dimethyl-
CC         2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl beta-D-
CC         glucuronate(out) + ADP + H(+) + phosphate; Xref=Rhea:RHEA:61384,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:144584, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61385;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-methylumbelliferone beta-D-glucuronate(in) + ATP + H2O = 4-
CC         methylumbelliferone beta-D-glucuronate(out) + ADP + H(+) + phosphate;
CC         Xref=Rhea:RHEA:61372, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:144582,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61373;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-
CC         benzothiazol-6-yl sulfate(in) + ATP + H2O = 5,7-dimethyl-2-
CC         methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl sulfate(out) +
CC         ADP + H(+) + phosphate; Xref=Rhea:RHEA:61376, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:144583, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61377;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol 17-O-(beta-D-glucuronate)(in) + ATP + H2O =
CC         17beta-estradiol 17-O-(beta-D-glucuronate)(out) + ADP + H(+) +
CC         phosphate; Xref=Rhea:RHEA:60128, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:82961, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60129;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + methotrexate(in) = ADP + H(+) + methotrexate(out)
CC         + phosphate; Xref=Rhea:RHEA:61356, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:50681, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61357;
CC         Evidence={ECO:0000250|UniProtKB:Q9UNQ0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + riboflavin(in) = ADP + H(+) + phosphate +
CC         riboflavin(out); Xref=Rhea:RHEA:61352, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57986, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q7TMS5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61353;
CC         Evidence={ECO:0000250|UniProtKB:Q7TMS5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + pheophorbide a(in) = ADP + H(+) + pheophorbide
CC         a(out) + phosphate; Xref=Rhea:RHEA:61360, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58687, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q7TMS5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61361;
CC         Evidence={ECO:0000250|UniProtKB:Q7TMS5};
CC   -!- SUBUNIT: Homodimer; disulfide-linked. The minimal functional unit is a
CC       homodimer, but the major oligomeric form in plasma membrane is a
CC       homotetramer with possibility of higher order oligomerization up to
CC       homododecamers. {ECO:0000250|UniProtKB:Q9UNQ0}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15255930};
CC       Multi-pass membrane protein {ECO:0000255}. Apical cell membrane
CC       {ECO:0000269|PubMed:18451542}; Multi-pass membrane protein
CC       {ECO:0000255}. Mitochondrion membrane {ECO:0000250|UniProtKB:Q9UNQ0};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain capillary, kidney and
CC       small intestine. Lower expression in heart. Preferentially expressed
CC       (at protein level) on the luminal membrane of brain capillaries, in
CC       kidney and small intestine. {ECO:0000269|PubMed:15255930,
CC       ECO:0000269|PubMed:18451542}.
CC   -!- INDUCTION: Down-regulated upon ischemia-reperfusion.
CC       {ECO:0000269|PubMed:18451542}.
CC   -!- DOMAIN: The extracellular loop 3 (ECL3) is involved in binding
CC       porphyrins and transfer them to other carriers, probably albumin.
CC       {ECO:0000250|UniProtKB:Q9UNQ0}.
CC   -!- PTM: N-glycosylated in brain capillary, kidney and small intestine but
CC       not in heart. {ECO:0000269|PubMed:15255930}.
CC   -!- PTM: N-glycosylated. Glycosylation-deficient ABCG2 is normally
CC       expressed and functional. {ECO:0000250|UniProtKB:Q9UNQ0}.
CC   -!- PTM: Phosphorylated. Phosphorylation may regulate the localization to
CC       the plasma membrane, the homooligomerization and therefore, the
CC       activity of the transporter. {ECO:0000250|UniProtKB:Q9UNQ0}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCG family.
CC       Eye pigment precursor importer (TC 3.A.1.204) subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB094089; BAC75666.1; -; mRNA.
DR   EMBL; AB105817; BAC76396.1; -; mRNA.
DR   EMBL; AY089996; AAM09106.1; -; mRNA.
DR   EMBL; AY089997; AAM09107.1; -; mRNA.
DR   EMBL; AY089998; AAM09108.1; -; mRNA.
DR   EMBL; AY274118; AAP23237.1; -; mRNA.
DR   RefSeq; NP_852046.1; NM_181381.2.
DR   RefSeq; XP_006236634.1; XM_006236572.3.
DR   RefSeq; XP_006236635.1; XM_006236573.3.
DR   RefSeq; XP_006236636.1; XM_006236574.3.
DR   RefSeq; XP_006236638.1; XM_006236576.2.
DR   RefSeq; XP_008761183.1; XM_008762961.2.
DR   RefSeq; XP_017448109.1; XM_017592620.1.
DR   AlphaFoldDB; Q80W57; -.
DR   SMR; Q80W57; -.
DR   STRING; 10116.ENSRNOP00000075138; -.
DR   ChEMBL; CHEMBL3509585; -.
DR   GlyCosmos; Q80W57; 2 sites, No reported glycans.
DR   GlyGen; Q80W57; 2 sites.
DR   iPTMnet; Q80W57; -.
DR   PhosphoSitePlus; Q80W57; -.
DR   PaxDb; 10116-ENSRNOP00000009546; -.
DR   Ensembl; ENSRNOT00000009546.6; ENSRNOP00000009546.4; ENSRNOG00000007041.7.
DR   Ensembl; ENSRNOT00055018074; ENSRNOP00055014517; ENSRNOG00055010693.
DR   Ensembl; ENSRNOT00060039727; ENSRNOP00060032851; ENSRNOG00060022927.
DR   Ensembl; ENSRNOT00065018828; ENSRNOP00065014393; ENSRNOG00065011581.
DR   GeneID; 312382; -.
DR   KEGG; rno:312382; -.
DR   UCSC; RGD:631345; rat.
DR   AGR; RGD:631345; -.
DR   CTD; 9429; -.
DR   RGD; 631345; Abcg2.
DR   eggNOG; KOG0061; Eukaryota.
DR   GeneTree; ENSGT00940000160729; -.
DR   InParanoid; Q80W57; -.
DR   OMA; FWYYTFY; -.
DR   OrthoDB; 936137at2759; -.
DR   PhylomeDB; Q80W57; -.
DR   TreeFam; TF105211; -.
DR   BRENDA; 7.6.2.3; 5301.
DR   Reactome; R-RNO-1660661; Sphingolipid de novo biosynthesis.
DR   Reactome; R-RNO-189451; Heme biosynthesis.
DR   Reactome; R-RNO-189483; Heme degradation.
DR   Reactome; R-RNO-917937; Iron uptake and transport.
DR   Reactome; R-RNO-9753281; Paracetamol ADME.
DR   Reactome; R-RNO-9793528; Ciprofloxacin ADME.
DR   PRO; PR:Q80W57; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000007041; Expressed in duodenum and 18 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0031526; C:brush border membrane; ISS:UniProtKB.
DR   GO; GO:0098591; C:external side of apical plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0008559; F:ABC-type xenobiotic transporter activity; ISO:RGD.
DR   GO; GO:0042887; F:amide transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015225; F:biotin transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IPI:RGD.
DR   GO; GO:0015562; F:efflux transmembrane transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0032217; F:riboflavin transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015143; F:urate transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0015878; P:biotin transport; ISS:UniProtKB.
DR   GO; GO:1990748; P:cellular detoxification; ISO:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
DR   GO; GO:0060136; P:embryonic process involved in female pregnancy; IDA:RGD.
DR   GO; GO:0140115; P:export across plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0019389; P:glucuronoside metabolic process; IMP:RGD.
DR   GO; GO:0006869; P:lipid transport; IEA:UniProtKB-KW.
DR   GO; GO:1904479; P:negative regulation of intestinal absorption; IMP:RGD.
DR   GO; GO:0015711; P:organic anion transport; IDA:ARUK-UCL.
DR   GO; GO:0065003; P:protein-containing complex assembly; IDA:RGD.
DR   GO; GO:0097744; P:renal urate salt excretion; IEP:RGD.
DR   GO; GO:1904612; P:response to 2,3,7,8-tetrachlorodibenzodioxine; IEP:RGD.
DR   GO; GO:0097305; P:response to alcohol; IEP:RGD.
DR   GO; GO:0051593; P:response to folic acid; IEP:RGD.
DR   GO; GO:0032868; P:response to insulin; IEP:RGD.
DR   GO; GO:0010039; P:response to iron ion; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0032218; P:riboflavin transport; ISS:UniProtKB.
DR   GO; GO:0070633; P:transepithelial transport; ISO:RGD.
DR   GO; GO:0055085; P:transmembrane transport; IMP:RGD.
DR   GO; GO:0046415; P:urate metabolic process; ISO:RGD.
DR   GO; GO:0015747; P:urate transport; IMP:RGD.
DR   GO; GO:1990961; P:xenobiotic detoxification by transmembrane export across the plasma membrane; IDA:RGD.
DR   GO; GO:1990962; P:xenobiotic transport across blood-brain barrier; ISO:RGD.
DR   CDD; cd03213; ABCG_EPDR; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR013525; ABC2_TM.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR043926; ABCG_dom.
DR   InterPro; IPR050352; ABCG_transporters.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR48041; ABC TRANSPORTER G FAMILY MEMBER 28; 1.
DR   PANTHER; PTHR48041:SF92; BROAD SUBSTRATE SPECIFICITY ATP-BINDING CASSETTE TRANSPORTER ABCG2; 1.
DR   Pfam; PF01061; ABC2_membrane; 1.
DR   Pfam; PF19055; ABC2_membrane_7; 1.
DR   Pfam; PF00005; ABC_tran; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Disulfide bond; Glycoprotein; Lipid transport;
KW   Membrane; Mitochondrion; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Translocase; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..657
FT                   /note="Broad substrate specificity ATP-binding cassette
FT                   transporter ABCG2"
FT                   /id="PRO_0000093390"
FT   TOPO_DOM        1..395
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        396..416
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        417..428
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        429..449
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        450..477
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        478..498
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        499..506
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        507..527
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        528..535
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        536..556
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        557..632
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        633..653
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        654..657
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          48..285
FT                   /note="ABC transporter"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   DOMAIN          389..653
FT                   /note="ABC transmembrane type-2"
FT   REGION          1..25
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..23
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         79..86
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   BINDING         183..189
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNQ0"
FT   BINDING         210
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNQ0"
FT   BINDING         242
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNQ0"
FT   CARBOHYD        596
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        600
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        592..610
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNQ0"
FT   DISULFID        603
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNQ0"
FT   CONFLICT        363..365
FT                   /note="AFR -> PFK (in Ref. 1; BAC75666)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        431
FT                   /note="F -> L (in Ref. 1; BAC75666)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        492
FT                   /note="I -> L (in Ref. 3; AAM09106/AAM09107/AAM09108)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        502
FT                   /note="T -> L (in Ref. 1; BAC75666)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        510
FT                   /note="M -> R (in Ref. 1; BAC75666)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   657 AA;  72961 MW;  C975C61A08489027 CRC64;
     MSSSNDHVLV PMSQRNKNGL PGMSSRGART LAEGDVLSFH HITYRVKVKS GFLVRKTAEK
     EILSDINGIM KPGLNAILGP TGGGKSSLLD VLAARKDPRG LSGDVLINGA PQPANFKCSS
     GYVVQDDVVM GTLTVRENLQ FSAALRLPKA MKTHEKNERI NTIIKELGLD KVADSKVGTQ
     FTRGISGGER KRTSIGMELI TDPSILFLDE PTTGLDSSTA NAVLLLLKRM SKQGRTIIFS
     IHQPRYSIFK LFDSLTLLAS GKLMFHGPAQ KALEYFASAG YHCEPYNNPA DFFLDVINGD
     SSAVMLNRGE QDHEANKTEE PSKREKPIIE NLAEFYINST IYGETKAELD QLPVAQKKKG
     SSAFREPVYV TSFCHQLRWI ARRSFKNLLG NPQASVAQLI VTVILGLIIG ALYFGLKNDP
     TGMQNRAGVF FFLTTNQCFT SVSAVELFVV EKKLFIHEYI SGYYRVSSYF FGKLVSDLLP
     MRFLPSVIYT CILYFMLGLK RTVEAFFIMM FTLIMVAYTA SSMALAIAAG QSVVSVATLL
     MTISFVFMML FSGLLVNLRT IGPWLSWLQY FSIPRYGFTA LQHNEFLGQE FCPGLNVTMN
     STCVNSYTIC TGNDYLINQG IDLSPWGLWR NHVALACMII IFLTIAYLKL LFLKKYS
//
